Project Grant R21DA063855
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $2.44 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 15, 2025, with completion targeted for March 31, 2030. The TEAM-UP (Tobacco Treatment Navigators Uniting with Primary Care) initiative addresses tobacco use disorder, which accounts for approximately 500,000 premature deaths annually in the United...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Oklahoma Health Sciences Center a Project Grant of $1,505,402 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025, through May 31, 2030. This research initiative addresses addiction science and public health policy by investigating the addiction potential, flavoring content, and substitutability of concept-flavored cigarillos—products that...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $144,372.00 to The Washington University under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 15, 2026, with completion targeted for April 30, 2031. This K02 Career Development Award supports integrated research and career development activities focused on advancing the implementation speed and scale-up of personalized tobacco use treatment approaches. The project...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $2.29 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025, with completion targeted for March 31, 2030. The grant supports a comprehensive research initiative examining opioid use disorder (OUD) treatment delivery via telehealth within community health centers (CHCs). The study utilizes nearly a decade of...
- Federal Grant Award Summary Clemson University's Division of Research received a $353,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2025, with a completion date of May 31, 2030. This K01 Career Development Award supports an Assistant Professor's research and professional development plan focused on electronic cigarettes (ECs) as a harm reduction strategy for individuals with opioid use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Miriam Hospital a $1.53 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the effects of endogenous and exogenous ovarian hormones on electronic nicotine delivery systems (ENDS) use. The award, obligated on August 1, 2025, with an ultimate completion date of April 30, 2030, directly addresses a critical public health gap identified by the U.S....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University's Health Sciences Division a $581,543 Project Grant on April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial of the Sense2Quit mobile health (mHealth) application for smoking cessation among people with HIV (PWH). The research addresses a critical public health disparity, as PWH experience smoking rates three to four times...
- Federal Project Grant Award Summary The University of Oregon received a $149,000 Project Grant award (effective July 1, 2025, through June 30, 2027) from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal secondary analysis examining the developmental trajectories of parasympathetic nervous system (PNS) functioning in children prenatally exposed to tobacco and/or cannabis. The research deliverables include multi-method,...
- Federal Project Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 15, 2025, with a completion date of June 30, 2027. The award funds research to develop innovative photopharmacological tools for investigating tetrahydrocannabinol (THC) signaling mechanisms in brain reward circuits. The primary deliverable is the advancement...
The National Institute on Drug Abuse (NIDA) awarded Oregon Health & Science University a Project Grant totaling $452,522 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods implementation research study examining electronic nicotine delivery systems (ENDS) assessment and cessation support practices in primary care settings. The award was obligated on May 1, 2026, with a completion date of April 30, 2028. The research will analyze current assessment and electronic health record documentation of ENDS use among patients ages 12 and older across 22 primary care clinics serving more than 154,000 patients, while identifying patient, provider, and clinic-level factors associated with both ENDS use assessment and cessation assistance offers for patients seeking to quit. The study is guided by the Consolidated Framework for Implementation Research (CFIR) and the Exploration, Preparation, Implementation, and Sustainment (EPIS) Framework to generate evidence-based strategies for improving ENDS assessment and cessation support in primary care. This research addresses a critical gap in implementation science, as prior studies indicate that ENDS use assessment in primary care ranges from only 1-34% despite healthcare authority recommendations and data showing that approximately 60% of young people and adults want to quit ENDS use. The deliverables will inform opportunities and strategies to enhance clinician knowledge and confidence in discussing ENDS use with patients and increasing the provision of cessation assistance.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $452.5k | 5/1/26 |